John Bartlett
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- HIV/AIDS drug development and treatment 8
- HIV/AIDS Research and Interventions 7
- Epidemiology 13
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Co-authors
- David N. Gilbert (3 shared papers)Brad Spellberg (2 shared papers)Louis B. Rice (1 shared paper)John E. Edwards (1 shared paper)George H. Talbot (1 shared paper)John S. Bradley (1 shared paper)Michael Scheld (1 shared paper)Helen W. Boucher (1 shared paper)
- Journals
- Clinical Infectious Diseases (5 papers)The Journal of Infectious Diseases (2 papers)The American Journal of Gastroenterology (1 paper)New England Journal of Medicine (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
John Bartlett
36 papers receiving 5.1k citations
John Bartlett's Hit Papers
Peers
Comparison fields: 5 of 140
- Molecular Medicine 2.0k
- Applied Microbiology and Biotechnology 631
- Microbiology 483
- Endocrinology 349
- Clinical Biochemistry 377
Countries citing papers authored by John Bartlett
This map shows the geographic impact of John Bartlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Bartlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Bartlett more than expected).
Fields of papers citing papers by John Bartlett
This network shows the impact of papers produced by John Bartlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Bartlett. The network helps show where John Bartlett may publish in the future.
Co-authors
The 25 scholars most cited alongside John Bartlett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America Hit paper breakdown → | 2008 | 4084 |
| 2 | 2003 | 395 | |
| 3 | 1982 | 264 | |
| 4 | 2001 | 146 | |
| 5 | 1975 | 100 | |
| 6 | 2015 | 82 | |
| 7 | 1992 | 61 | |
| 8 | 2015 | 42 | |
| 9 | 2003 | 39 | |
| 10 | Updated guidelines for use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors | 2004 | 21 |
| 11 | Persistent colonization by haemophilus influenzae in chronic obstructive pulmonary disease | 2004 | 20 |
| 12 | The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for helicobacter pylori infections | 2004 | 19 |
| 13 | Treatment for adult HIV infection: 2004 recommendations of the international AIDS society-USA panel | 2004 | 17 |
| 14 | 2000 | 15 | |
| 15 | Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study | 2004 | 13 |
| 16 | 2006 | 12 | |
| 17 | 1992 | 8 | |
| 18 | No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: Randomized, double-blind, placebo-controlled trial | 2004 | 6 |
| 19 | Peginterferon alfa-2a Plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-Co-infected persons | 2004 | 6 |
| 20 | 2003 | 6 |
About John Bartlett
John Bartlett is a scholar working on Infectious Diseases, Epidemiology, Emergency Medicine, Hepatology and Virology, having authored 39 papers that have together received 5.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (7 papers), Hepatitis C virus research (6 papers), HIV-related health complications and treatments (6 papers), HIV Research and Treatment (4 papers), Antibiotic Resistance in Bacteria (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Molecular Medicine (2.0k citations), Applied Microbiology and Biotechnology (631 citations), Microbiology (483 citations), Endocrinology (349 citations) and Clinical Biochemistry (377 citations). John Bartlett has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include David N. Gilbert, Brad Spellberg, Louis B. Rice, John E. Edwards, George H. Talbot, John S. Bradley, Michael Scheld, Helen W. Boucher, Joseph S. Solomkin and Timothy R. Townsend. Their work appears in journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases, The American Journal of Gastroenterology, New England Journal of Medicine and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.